IC50, EC50 i Ki dla 5-HT2C: Antydepresanty
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor - PubMed
fluoxetine | Ligand Activity Charts | IUPHAR/BPS Guide to PHARMACOLOGY
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor - PubMed
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor - PubMed
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways - PubMed
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways - PubMed
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways - PubMed
Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties - PubMed
mirtazapine | Ligand Activity Charts | IUPHAR/BPS Guide to PHARMACOLOGY
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram - PubMed
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram - PubMed
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats | BMC Neuroscience | Full Text
Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus - PubMed
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments - PubMed
Trazodone is a potent agonist at 5-HT2C receptors mediating inhibition of the N-methyl-D-aspartate/nitric oxide/cyclic GMP pathway in rat cerebellum - PubMed
Trazodone is a potent agonist at 5-HT2C receptors mediating inhibition of the N-methyl-D-aspartate/nitric oxide/cyclic GMP pathway in rat cerebellum - PubMed
mirtazapine | Ligand Activity Charts | IUPHAR/BPS Guide to PHARMACOLOGY
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways - PubMed
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram - PubMed